BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23729584)

  • 1. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
    Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
    Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Ustymowicz M
    Adv Med Sci; 2011; 56(1):39-43. PubMed ID: 21555304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase of regenerating liver-3 induces angiogenesis by increasing extracellular signal-regulated kinase phosphorylation in endometrial adenocarcinoma.
    Ming J; Jiang Y; Jiang G; Zheng H
    Pathobiology; 2014; 81(1):1-7. PubMed ID: 23989302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer.
    Pryczynicz A; Guzińska-Ustymowicz K; Chang XJ; Kiśluk J; Kemona A
    Folia Histochem Cytobiol; 2010 Dec; 48(4):632-6. PubMed ID: 21478108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTP4A3 expression increases strongly in lymph node metastases from colorectal carcinoma.
    Guzinska-Ustymowicz K; Pryczynicz A; Kemona A
    Anticancer Res; 2009 Oct; 29(10):3913-6. PubMed ID: 19846928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
    Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
    Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
    Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
    Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
    Lou X; Liu Y; Lei JY; Li H
    Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
    Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
    Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
    Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
    Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
    Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
    Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
    Miskad UA; Semba S; Kato H; Yokozaki H
    Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
    Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
    Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
    Talvensaari-Mattila A; Santala M; Soini Y; Turpeenniemi-Hujanen T
    Anticancer Res; 2005; 25(6B):4101-5. PubMed ID: 16309203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.